SCHEMBL8396164

SCHEMBL8396164

Nc1cc2c3c(cccc3c1)C(=O)N(CCNCCCNCCN1C(=O)c3cccc4cc(N)cc(c34)C1=O)C2=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 3/20 0.75
HEXA P06865 11/20 0.68
HEXB P07686 11/20 0.68
OGA O60502 1/20 0.68
FTO Q9C0B1 2/20 0.64
CYP2D6 P10635 1/20 0.64
MEN1 O00255 2/20 0.62
POLB P06746 2/20 0.62
KMT2A Q03164 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
MAPT P10636 1/20 0.62
AHR P35869 1/20 0.62
RECQL P46063 1/20 0.62
RAB9A P51151 1/20 0.62
CYP1A2 P05177 1/20 0.61
TNNI3 P19429 1/20 0.61
MAPK1 P28482 1/20 0.61
STAT6 P42226 1/20 0.61
TNNT2 P45379 1/20 0.61
TNNC1 P63316 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9504104 0.96 SIRT1 (0.69) SIRT1HEXAHEXBOGAFTO
SCHEMBL9502888 0.96 HEXA (0.73) SIRT1HEXAHEXBOGAFTO
SCHEMBL10568369 0.94 SIRT1 (0.69) SIRT1HEXAHEXBOGAFTO
SCHEMBL9500472 0.92 SIRT1 (0.67) SIRT1HEXAHEXBOGAFTO
SCHEMBL9500513 0.92 SIRT1 (0.71) SIRT1HEXAHEXBOGAFTO
Elinafide SCHEMBL16213332 0.90 FTO (0.79) SIRT1HEXAHEXBOGAFTO
SCHEMBL9092319 0.89 SIRT1 (0.63) SIRT1HEXAHEXBOGAFTO
SCHEMBL9091823 0.88 SIRT1 (0.65) SIRT1HEXAHEXBOGAFTO
Elinafide SCHEMBL6256967 0.86 SIRT1 (1.00) SIRT1HEXAHEXBOGAMEN1
Elinafide SCHEMBL29441732 0.86 SIRT1 (1.00) SIRT1HEXAHEXBOGAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160175292-A1 Antioxidants Having Aromatic Structures Reacting with Superoxide TOUR JAMES (US) 2016-06-23 US disclosed
US-5981753-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1999-11-09 US disclosed
EP-0714387-B1 NEW BIS-NAPHTHALIMIDES FOR THE TREATMENT OF CANCER BASF AG (DE) 1998-05-27 EP disclosed
US-5616589-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1997-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160175292-A1 Antioxidants Having Aromatic Structures Reacting with Superoxide GPX4, TXN2, MPO SIRT1 851/4885HEXA 2410/4885HEXB 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.